Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab007790-10μg | 10μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $39.90 | |
Ab007790-50μg | 50μg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $117.90 | |
Ab007790-100μg | 100μg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $198.90 | |
Ab007790-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $417.90 |
Recombinant(34G7); Mouse anti Human Pepsinogen II (PGII) Antibody; Detection antibody, ELISA, CLIA; Unconjugated
Product Name | Recombinant Pepsinogen II (PGII) Antibody - Primary antibody, for ELISA,CLIA,Detection antibody various applications, from Human, generated in Mouse, specific to PGII , IgG1 |
---|---|
Synonyms | EC 3.4.23.3 | Pepsinogen C |
Specifications & Purity | ExactAb™, Validated, Carrier Free, Azide Free, Recombinant, Lot by Lot |
Host Species | Mouse |
Host species | Mouse |
Specificity | PGII |
Application | ELISA,CLIA,Detection antibody |
Immunogen | E. coli-derived recombinant human PGII |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Recombinant, Validated |
Product Description | Recombinant Pepsinogen II (PGII) Antibody, 34G7, is a Detection antibody could be used for ELISA, CLIA at 1.0µg/mL. |
Antibody Type | Primary antibody |
---|---|
Clonality | Recombinant |
Isotype | IgG1 |
SDS-PAGE | 150 kDa |
Purification Method | Protein A purified |
Matched Pairs | [Ab007791] Recombinant Pepsinogen II (PGII) antibody as Capture antibody |
Source | CHO supernatant |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Storage: -20℃ for long term storage. Avoid repeated freeze/thaw cycles. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Application | Dilution info |
---|---|
ELISA |
1 μg/mL |
CLIA |
1 μg/mL
|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ23F0600302 | Certificate of Analysis | Jun 13, 2023 | Ab007790 |
ZJ23F0600303 | Certificate of Analysis | Jun 13, 2023 | Ab007790 |
1. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P et al.. (2004) The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).. Genome Res, 14 (10B): (2121-7). [PMID:15489334] [10.1021/op500134e] |
2. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K et al.. (2004) Complete sequencing and characterization of 21,243 full-length human cDNAs.. Nat Genet, 36 (1): (40-5). [PMID:14702039] [10.1021/op500134e] |
3. Ostermann N, Ruedisser S, Ehrhardt C, Breitenstein W, Marzinzik A, Jacoby E, Vangrevelinghe E, Ottl J, Klumpp M, Hartwieg JC, Cumin F, Hassiepen U, Trappe J, Sedrani R, Geisse S, Gerhartz B, Richert P, Francotte E, Wagner T, Krömer M, Kosaka T, Webb RL, Rigel DF, Maibaum J, Baeschlin DK.. (2013) A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.. J Med Chem, 56 (6): (2196-2206). [PMID:23360239] [10.1021/jm301706j] |
4. Sellner H, Cottens S, Cumin F, Ehrhardt C, Kosaka T, Lorthiois E, Ostermann N, Webb RL, Rigel DF, Wagner T, Maibaum J.. (2015) trans-3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: prime site exploration using an oxygen linker.. Bioorg Med Chem Lett, 25 (8): (1787-1791). [PMID:25754490] [10.1016/j.bmcl.2015.02.040] |
5. Athauda, S B SB, Tanji, M M, Kageyama, T T and Takahashi, K K.. (1989) A comparative study on the NH2-terminal amino acid sequences and some other properties of six isozymic forms of human pepsinogens and pepsins.. Journal of biochemistry, [PMID:2515193] |
6. Pals, G G and 8 more authors.. (1989) Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21.1-pter.. Genomics, [PMID:2567697] |
7. Taggart, R T RT and 6 more authors.. (1989) Human pepsinogen C (progastricsin). Isolation of cDNA clones, localization to chromosome 6, and sequence homology with pepsinogen A.. The Journal of biological chemistry, (5): [PMID:2909526] |
8. Hayano, T T, Sogawa, K K, Ichihara, Y Y, Fujii-Kuriyama, Y Y and Takahashi, K K.. (1988) Primary structure of human pepsinogen C gene.. The Journal of biological chemistry, (25): [PMID:3335549] |
9. Foltmann, B B and Jensen, A L AL.. (1982) Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart.. European journal of biochemistry, [PMID:6816595] |
10. Moore, S A SA, Sielecki, A R AR, Chernaia, M M MM, Tarasova, N I NI and James, M N MN.. (1995) Crystal and molecular structures of human progastricsin at 1.62 A resolution.. Journal of molecular biology, (31): [PMID:7714902] |
11. Khan, A R AR, Cherney, M M MM, Tarasova, N I NI and James, M N MN.. (1997) Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin.. Nature structural biology, [PMID:9406551] |
12. Mungall, A J AJ and 170 more authors.. (2003) The DNA sequence and analysis of human chromosome 6.. Nature, (23): [PMID:14574404] |